TotalMarketCap

Biodesix

BDSXNasdaq United StatesHealth CareMedical Specialities

Market cap

$211.022 M

$20.00 -6.93%

Close of 6 Nov 2026

As of 6 Nov 2026, Biodesix (BDSX) has a market capitalization of $211.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$88.5M

#2524 by revenue

Earnings

-$35.3M

Loss-making

Shares outstanding

11,088,511

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical Specialities, ranked by market cap

All 44 →
  1. #32Fulgent GeneticsFLGT$511.0M
  2. #33TriSalus Life SciencesTLSI$217.4M
  3. #34BiodesixBDSX$211.0M
  4. #35ExagenXGN$181.4M
  5. #36Burning Rock BiotechBNR$139.2M

What if Biodesix were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,676,197

Per share 133,810× higher

Bitcoin $1.53T

$144,804.38

Per share 7,240× higher

Apple $5.02T

$475,379.26

Per share 23,769× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Biodesix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.